MK-1775, a first-in-class small-molecule inhibitor of WEE1 with undergoing clinical evaluation, abated phosphorylation of CDK1 at Tyr15 and caused mitotic catastrophe in cancer cells (Kreahling et al., 2013). This evidence concerns the gene CDK1 and cancer.